Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in JIA-associated uveitis
NCT03816397Phase 4Completed
- Start
- Mar 2020
- Primary completion
- Jan 2025
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 4 trial of adalimumab in uveitis, anterior uveitis (AU). Started Mar 2020; status: completed.
02
Drugs
03
Conditions
uveitisanterior uveitis (AU)
Beyond the preview
Go deeper on NCT03816397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03816397.